173 related articles for article (PubMed ID: 23671581)
1. A novel function of novobiocin: disrupting the interaction of HIF 1α and p300/CBP through direct binding to the HIF1α C-terminal activation domain.
Wu D; Zhang R; Zhao R; Chen G; Cai Y; Jin J
PLoS One; 2013; 8(5):e62014. PubMed ID: 23671581
[TBL] [Abstract][Full Text] [Related]
2. Complex regulation of the transactivation function of hypoxia-inducible factor-1 alpha by direct interaction with two distinct domains of the CREB-binding protein/p300.
Ruas JL; Berchner-Pfannschmidt U; Malik S; Gradin K; Fandrey J; Roeder RG; Pereira T; Poellinger L
J Biol Chem; 2010 Jan; 285(4):2601-9. PubMed ID: 19880525
[TBL] [Abstract][Full Text] [Related]
3. Menadione and ethacrynic acid inhibit the hypoxia-inducible factor (HIF) pathway by disrupting HIF-1α interaction with p300.
Na YR; Han KC; Park H; Yang EG
Biochem Biophys Res Commun; 2013 May; 434(4):879-84. PubMed ID: 23618863
[TBL] [Abstract][Full Text] [Related]
4. Insights from molecular dynamics simulations and steered molecular dynamics simulations to exploit new trends of the interaction between HIF-1α and p300.
Yu Z; Liu Y; Zhu J; Han J; Tian X; Han W; Zhao L
J Biomol Struct Dyn; 2020 Jan; 38(1):1-12. PubMed ID: 30784357
[TBL] [Abstract][Full Text] [Related]
5. Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1α interaction with cofactors p300/CBP.
Yin S; Kaluz S; Devi NS; Jabbar AA; de Noronha RG; Mun J; Zhang Z; Boreddy PR; Wang W; Wang Z; Abbruscato T; Chen Z; Olson JJ; Zhang R; Goodman MM; Nicolaou KC; Van Meir EG
Clin Cancer Res; 2012 Dec; 18(24):6623-33. PubMed ID: 22923450
[TBL] [Abstract][Full Text] [Related]
6. An allosteric peptide inhibitor of HIF-1α regulates hypoxia-induced retinal neovascularization.
Usui-Ouchi A; Aguilar E; Murinello S; Prins M; Gantner ML; Wright PE; Berlow RB; Friedlander M
Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28297-28306. PubMed ID: 33106407
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin and doxorubicin repress Vascular Endothelial Growth Factor expression and differentially down-regulate Hypoxia-inducible Factor I activity in human ovarian cancer cells.
Duyndam MC; van Berkel MP; Dorsman JC; Rockx DA; Pinedo HM; Boven E
Biochem Pharmacol; 2007 Jul; 74(2):191-201. PubMed ID: 17498666
[TBL] [Abstract][Full Text] [Related]
8. p300 and p53 levels determine activation of HIF-1 downstream targets in invasive breast cancer.
Vleugel MM; Shvarts D; van der Wall E; van Diest PJ
Hum Pathol; 2006 Aug; 37(8):1085-92. PubMed ID: 16867872
[TBL] [Abstract][Full Text] [Related]
9. CITED2 controls the hypoxic signaling by snatching p300 from the two distinct activation domains of HIF-1α.
Yoon H; Lim JH; Cho CH; Huang LE; Park JW
Biochim Biophys Acta; 2011 Dec; 1813(12):2008-16. PubMed ID: 21925214
[TBL] [Abstract][Full Text] [Related]
10. Structural Elucidation and Synthesis of Eudistidine A: An Unusual Polycyclic Marine Alkaloid that Blocks Interaction of the Protein Binding Domains of p300 and HIF-1α.
Chan ST; Patel PR; Ransom TR; Henrich CJ; McKee TC; Goey AK; Cook KM; Figg WD; McMahon JB; Schnermann MJ; Gustafson KR
J Am Chem Soc; 2015 Apr; 137(16):5569-75. PubMed ID: 25892103
[TBL] [Abstract][Full Text] [Related]
11. Modulation of p300 binding by posttranslational modifications of the C-terminal activation domain of hypoxia-inducible factor-1alpha.
Cho H; Ahn DR; Park H; Yang EG
FEBS Lett; 2007 Apr; 581(8):1542-8. PubMed ID: 17382325
[TBL] [Abstract][Full Text] [Related]
12. DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX.
Kaluzová M; Kaluz S; Lerman MI; Stanbridge EJ
Mol Cell Biol; 2004 Jul; 24(13):5757-66. PubMed ID: 15199132
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances in the Discovery of HIF-1α-p300/CBP Inhibitors as Anti-Cancer Agents.
Wei J; Yang Y; Lu M; Lei Y; Xu L; Jiang Z; Xu X; Guo X; Zhang X; Sun H; You Q
Mini Rev Med Chem; 2018; 18(4):296-309. PubMed ID: 27484627
[TBL] [Abstract][Full Text] [Related]
14. Src induces expression of carbonic anhydrase IX via hypoxia-inducible factor 1.
Takacova M; Holotnakova T; Barathova M; Pastorekova S; Kopacek J; Pastorek J
Oncol Rep; 2010 Mar; 23(3):869-74. PubMed ID: 20127031
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the HIF1α-p300 interaction by quinone- and indandione-mediated ejection of structural Zn(II).
Jayatunga MK; Thompson S; McKee TC; Chan MC; Reece KM; Hardy AP; Sekirnik R; Seden PT; Cook KM; McMahon JB; Figg WD; Schofield CJ; Hamilton AD
Eur J Med Chem; 2015 Apr; 94():509-16. PubMed ID: 25023609
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia inducible factor (HIf1alpha and HIF2alpha) and carbonic anhydrase 9 (CA9) expression and response of head-neck cancer to hypofractionated and accelerated radiotherapy.
Koukourakis MI; Giatromanolaki A; Danielidis V; Sivridis E
Int J Radiat Biol; 2008 Jan; 84(1):47-52. PubMed ID: 17852557
[TBL] [Abstract][Full Text] [Related]
17. Anticancer osmium complex inhibitors of the HIF-1α and p300 protein-protein interaction.
Yang C; Wang W; Li GD; Zhong HJ; Dong ZZ; Wong CY; Kwong DW; Ma DL; Leung CH
Sci Rep; 2017 Feb; 7():42860. PubMed ID: 28225008
[TBL] [Abstract][Full Text] [Related]
18. Proteasomal inhibition attenuates transcriptional activity of hypoxia-inducible factor 1 (HIF-1) via specific effect on the HIF-1alpha C-terminal activation domain.
Kaluz S; Kaluzová M; Stanbridge EJ
Mol Cell Biol; 2006 Aug; 26(15):5895-907. PubMed ID: 16847340
[TBL] [Abstract][Full Text] [Related]
19. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
Lim CS; Kiriakidis S; Paleolog EM; Davies AH
J Vasc Surg; 2012 May; 55(5):1427-39. PubMed ID: 22277691
[TBL] [Abstract][Full Text] [Related]
20. Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1.
Bhattacharya S; Michels CL; Leung MK; Arany ZP; Kung AL; Livingston DM
Genes Dev; 1999 Jan; 13(1):64-75. PubMed ID: 9887100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
